Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial
Claudio Cerchione(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Vincenzo Martinelli(Federico II University Hospital), Cristiano Minucci(Federico II University Hospital), Sonia Ronconi(Istituti di Ricovero e Cura a Carattere Scientifico), Angela Gravetti(Ospedale Antonio Cardarelli), Sara Bravaccini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Fabrizio Pane(Federico II University Hospital), Marco Picardi(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Mattia Altini(Agenzia Sanitaria e Sociale Regionale), Aniello Casoria(Federico II University Hospital), Davide Nappi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Ilaria Santoriello(Federico II University Hospital), Ugo De Giorgi(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Giovanni Martinelli(University of Bologna), Maria Benedetta Giannini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Delia Cangini(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Novella Pugliese(University of Naples Federico II), Andrea Ghelli Luserna di Rorà(Fondazione Pisa)
Cited by 6
Related Papers
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.
|PubMed|2006|909
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Levofloxacin to Prevent Bacterial Infection in Patients with Cancer and Neutropenia
|New England Journal of Medicine|2005|644